QTc intervals are prolonged in (near)term neonates during therapeutic hypothermia to normalise immediately afterwards
暂无分享,去创建一个
[1] S. Mallayasamy,et al. Pharmacometric approach to assist dosage regimen design in neonates undergoing therapeutic hypothermia , 2021, Pediatric Research.
[2] J. N. van den Anker,et al. Dose‐Related Adverse Drug Events in Neonates: Recognition and Assessment , 2021, Journal of clinical pharmacology.
[3] G. Pichler,et al. Successful Postnatal Cardiopulmonary Resuscitation Due to Defibrillation , 2021, Children.
[4] P. Graaf. Toward Replacement of Thorough QT Studies , 2021 .
[5] D. Strauss,et al. Translational Models and Tools to Reduce Clinical Trials and Improve Regulatory Decision Making for QTc and Proarrhythmia Risk (ICH E14/S7B Updates) , 2020, Clinical pharmacology and therapeutics.
[6] W. Slikker,et al. Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs , 2020, Pharmaceutics.
[7] A. Smits,et al. A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates , 2020, Frontiers in Pharmacology.
[8] J. N. van den Anker,et al. Perspectives in Neonatal Pharmacology: Drug Discovery, Knowledge Integration and Structured Prioritization. , 2019, Current pharmaceutical design.
[9] S. Paglialunga,et al. QT Assessment in Early Drug Development: The Long and the Short of It , 2019, International journal of molecular sciences.
[10] E. D. del Giudice,et al. Electrocardiographic and echocardiographic changes during therapeutic hypothermia in encephalopathic infants with long-term adverse outcome. , 2018, Resuscitation.
[11] D. Tibboel,et al. Non‐maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] R. Portman,et al. Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates , 2017, Pediatric Research.
[13] P. Neužil,et al. Inducibility of ventricular fibrillation during mild therapeutic hypothermia: electrophysiological study in a swine model , 2015, Journal of Translational Medicine.
[14] M. Ackerman,et al. Heart-Rate-Corrected QT Interval Evolution in Premature Infants During the First Week of Life , 2014, Pediatric Cardiology.
[15] F. Schena,et al. Heart Rate and Arterial Pressure Changes during Whole-Body Deep Hypothermia , 2013, ISRN pediatrics.
[16] P. Davis,et al. Cooling for newborns with hypoxic ischaemic encephalopathy. , 2013, The Cochrane database of systematic reviews.
[17] G. Buonocore,et al. Therapeutic hypothermia in a late preterm infant , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[18] L. Doyle,et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. , 2011, Archives of pediatrics & adolescent medicine.
[19] G. Simbruner,et al. Systemic Hypothermia After Neonatal Encephalopathy: Outcomes of neo.nEURO.network RCT , 2010, Pediatrics.
[20] A. Arısoy,et al. Effect of domperidone on the QTc interval in premature infants , 2009, Journal of Perinatology.
[21] S. Shankaran,et al. Changes in the PQRST Intervals and Heart Rate Variability Associated with Rewarming in Two Newborns Undergoing Hypothermia Therapy , 2009, Neonatology.
[22] A. Edwards,et al. The effect of temperature on the QTc interval in the newborn infant receiving extracorporeal membrane oxygenation (ECMO). , 2007, Early human development.
[23] E. Jaeggi,et al. 24-Hour Electrocardiogram before and during Cisapride Treatment in Neonates and Infants , 2004, Neonatology.
[24] F. Cools,et al. A comparison of the pharmacokinetics of two dosing regimens of cisapride and their effects on corrected QT interval in premature infants , 2003, European Journal of Clinical Pharmacology.
[25] A. Gunn,et al. Treatment of Term Infants With Head Cooling and Mild Systemic Hypothermia (35.0°C and 34.5°C) After Perinatal Asphyxia , 2003 .
[26] A. Gunn,et al. Brain Hypothermia and QT Interval , 1999, Pediatrics.
[27] D. Albert,et al. [Corrected QT interval during therapeutic hypothermia in hypoxic ischaemic encephalopathy]. , 2016, Anales de pediatria.
[28] S. Liao,et al. Case 2: Corrected QT Prolongation and Bradycardia During Therapeutic Hypothermia in an Infant , 2016 .